Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: USPTO: '749 Amendment Req Reconsideration After Non Final Rejection 1-19-10

IMO, the amended claims appear to be minor clarifications of earlier claims, i.e., no substantial changes have occured to their meaning. I interpret this as good news. We will now have to wait for the examiner to respond. Hopefully a NIRC is lurking around the corner.

Cheers,

DG

Share
New Message
Please login to post a reply